← Evidence map

ArticleFrontiers in neurology2022

MELK is a prognostic biomarker and correlated with immune infiltration in glioma.

Haiyan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36353126